# Effect of Eplerenone on Endothelial Function in Metabolic Syndrome

> **NCT01319344** · PHASE3 · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 42 (actual)

## Conditions studied

- Metabolic Syndrome
- Endothelial Dysfunction

## Interventions

- **DRUG:** Eplerenone

## Key facts

- **NCT ID:** NCT01319344
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319344, "Effect of Eplerenone on Endothelial Function in Metabolic Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01319344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*